Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Pacific Biosciences (PACB): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Neutral
16 analysts
Options Flow (P/C)
3.46
More puts — Bearish
Avg Consensus PT
$2
+74.7%
Highest Price Target
$4
+203.7%
Lowest Price Target
$1
+2.5%
Short Interest
18.3%
Declining — Bullish
Insider Activity (30d)
Net Seller
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Sep 9, 2026 | UBS | Doug Schenkel— | +2.5% | $2 → $1 | Assumes | Neutral |
| May 11, 2026 | Barclays | Luke Sergott— | +13.9% | $1 → $2 | Maintained | Underweight |